More Business Wire
View Older Stories View Newer Stories-
Summit Health Physicians Earn National Recognition as 2025 Jersey Choice “Top Doctors”
-
PitchBook Expands Credit Research Suite with New CLO Portfolio Holdings Universe
-
A2 Biotherapeutics Presents Initial Safety and Efficacy Data from Ongoing Phase 1/2 EVEREST-2 Study, Including First Report of a Complete Response to CAR T-Cell Therapy in a Patient with NSCLC
-
Vir Biotechnology to Participate in the Jefferies 2025 London Healthcare Conference
-
Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducte
-
Indapta Therapeutics Presents Data Demonstrating Clinical Activity of its Allogeneic Natural Killer Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma
-
James Hardie Announces Participation At Upcoming Investor Conferences and Timing of Second Quarter FY26 Earnings Release & Conference Call
-
Malar Group Announces Strategic Investment In Spendsafe To Transform Financial Literacy For The Next Generation
-
Stewart Strengthens Real Estate Services Portfolio by Announcing its Intent to Acquire Mortgage Contracting Services (MCS)
-
Experian Named a Leader in IDC MarketScape: Worldwide Identity Verification in Financial Services 2025 Vendor Assessment
-
Intapp DealCloud named Deal Origination Solution of the Year: Credit at the 2025 Private Equity Wire U.S. Awards
-
Knight-Swift Transportation Holdings Inc. Announces Quarterly Cash Dividend
-
Taxbit Wins the Digital Banker’s 2025 Digital Assets Award for Best Technology Solution Provider for Digital Assets - Tax & Compliance Automation
-
CoreTrust Partners with NPI to Launch Exclusive Solution for Smarter IT Spend Management
-
Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease
-
Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
-
TITAN Group’s Credit Rating Improved to “BB+ with Positive Outlook” by S&P Global Ratings
-
ASA Launches AI-Driven Suite to Help Credit Unions and Banks Strengthen Engagement, Simplify Data, and Deliver Smarter Financial Wellness Tools
-
The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University
-
Afya Limited Announces Medical Seats Increase in AFYA Faculdade de Ciências Médicas Bragança
-
Auna Announces Completion of US$765 million Debt Refinancing
-
Franklin Resources, Inc. Announces Preliminary Fourth Quarter and Fiscal Year Results
-
AIR, the World’s Largest Flavored Hookah Producer and Owner of the Iconic Al Fakher Brand, to Become a Public Company through a Business Combination with Cantor Equity Partners III
-
England Family Foundation Deploys $1 Million in Emergency Funds to Support DC Residents Affected by Federal Pay and SNAP Benefit Freezes
-
BlackSky CEO Brian O‘Toole Named ‘Executive of the Year’ at the 2025 Greater Washington GovCon Awards
-
Rand Capital Reports Third Quarter 2025 Results
-
Gilead Provides Update on Phase 3 ASCENT-07 Study
-
Sidus Space to Host Third Quarter Financial Results Conference Call on November 14 at 5:00 p.m. ET
-
Odyssey Marine Exploration Files U.S. Offshore Critical Minerals Lease Sale Request to Advance America’s Resource Security
-
Graham Packaging Company Inc. to Review 2025 Third Quarter Results on November 11, 2025
-
Orion S.A. Names Jonathan Puckett Chief Financial Officer
-
Warner Music Group Corp. Announces Quarterly Cash Dividend
-
Institut Choiseul Releases Strategic Paper: “From Economic Emergence to Strategic Influence – Drivers and Challenges for Morocco 2035”
-
Rachelle Alexis Lim is appointed CEO of MultiSafepay as the Company Aims to Better Serve European SMEs with Innovative Solutions
-
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®
-
Trinity Place Holdings Inc. Reports Third Quarter Financial Results
-
Tredegar Reports Third Quarter 2025 Results
-
ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of October 31, 2025
-
Global Partners Reports Third-Quarter 2025 Financial Results
-
Marcus & Millichap, Inc. Reports Results for Third Quarter 2025
-
One Equity Partners Exits Investment in InfuCare Rx
-
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
-
Dechra Advances Public Health as Newest Human-Animal Bond Certified Company
-
KB Home Announces the Grand Opening of Three New Communities Within the Highly Desirable Tivoli Master Plan in Modesto, California
-
Guardant Health to Participate in Upcoming Investor Conferences
-
Shop Early, Save Big: Kohl’s Black Friday Savings Start Now
-
CrowdStrike’s Fal.Con 2026 Takes Over Mandalay Bay and Launches the Day Zero Threat Summit
-
ACP Completes Growth Capital Investment in Advantage Investigations
-
Strategy Announces Pricing of Initial Public Offering of € Denominated STRE Stock
-
ChargePoint CEO Named to 2025 TIME100 Climate List
